← Leaderboards
Matthew Zachary Madden
Vanderbilt University
$129,961
Attributed
$129,961
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51.8K · FY2020–22$100K$75K$50K$25K$0
'20
'21
'22
Funding mix
By agency
NIH$129,961 · 1
By mechanism
F30$129,961 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Ann Richmond$15,857,391
- Jordan D Berlin$14,361,518
- Wenbiao Chen$6,468,374
- Julio E Ayala$4,587,157
- Nikki Cheng$4,462,144
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectAlpha KetoglutarateAnti-CancerAnticancer ActivityAntineoplastic AgentsAnti-Pd1 AntibodiesAnti-Pd1 TherapyB-Cell Acute Lymphoblastic LeukemiaCancer CellCancer ImmunotherapyCancer TherapyCd19 GeneCd4 Positive T LymphocytesCd8b1 GeneCd8-Positive T-LymphocytesCell Differentiation ProcessCell PhysiologyCellsCell SurvivalCellular Metabolic ProcessChimeric Antigen Receptor T CellsChronicCitric Acid CycleAerobic Glycolysis
Grant awards (3)
Glycolysis and Glutaminase in CD8 T cell differentiation and anti-tumor immunity$51,752
F30 · FY2022 · CA · contact PI
Glycolysis and Glutaminase in CD8 T cell differentiation and anti-tumor immunity$47,980
F30 · FY2021 · CA · contact PI
Glycolysis and Glutaminase in CD8 T cell differentiation and anti-tumor immunity$30,229
F30 · FY2020 · CA · contact PI